Skip to main content
Search form
Search
Medicines for Malaria Venture
Developing antimalarials to save lives
Research & Development
MMV-supported projects
R&D areas of work
Next-generation medicines
Products for key populations
Working with regulators
Information for scientists
Malaria online course
Global health compound design webinars
Call for proposals
TPPs & TCPs
Learning resources for scientists
Project of the year award
Computational chemistry
R&D challenges
Access
Products & projects
Product availability maps
Areas of work
Supporting introduction
Enhancing reach
Informing R&D
Gathering market intelligence
Tool Kits
Injectable Artesunate tool kit
Artesunate rectal capsules tool kit
Seasonal Malaria Chemoprevention tool kit
Access challenges
Partnering
The PDP model
Our partner network
Our donors
Current donors
Past donors
Donate to MMV
Socially responsible agreements
Our clinical centre partners
Our impact
Milestones
Real life stories
Better medicines for children
Gender equity
Global health security
Malaria and COVID-19
Tackling antimicrobial resistance
About us
What we do
An overview of our work
Our strategic focus
Our history
People & governance
Staff bios
Staff interviews
Board of Directors
MMV North America Board
Expert Scientific Advisory Committee
Access & Product Management Advisory Committee
Global Safety Board
Work with us
Jobs
RFPs/RFIs
Policies
Diversity at MMV
Funding and expenditure
FAQs
Contact us
Malaria & medicines
Definitions and symptoms
Five species
Parasite lifecycle
Malaria facts & figures
Malaria treatment
History of antimalarials
Newsroom
News & Press Releases
Audio
Media interviews
Speaking of Malaria podcast
Films
Infographics
Interviews
Image slideshows
Publications
Events
MMV Open
Malaria
Libre
About Malaria
Libre
Participate in Malaria
Libre
Malaria
Libre
data repository
MMVSola
About MMVSola
Pandemic Response Box
About the Pandemic Response Box
Request the Pandemic Response Box
Supporting information
Terms & conditions
COVID Box
About the COVID Box
Supporting information
COVID Box terms and conditions
Archived projects
Pathogen Box
Malaria Box
MMV Open Team
Contact us
Home
Newsroom
News & Press Releases
News & Press Releases
Filter
Category
All
News story
Press release
Topic
Access & product management
Donors
General
Open source
Partner
R&D
Search Terms
458 found
G-FINDER 2010: Good news with a twist in the tail for PDPs
18 Feb 2011
Jomaa Pharma and MMV to co-develop novel malaria treatment based on fosmidomycin
15 Feb 2011
Single-dose cure for malaria edges closer to the clinic
08 Feb 2011
MMV signs MoU with ALMA at the African Union Summit
03 Feb 2011
Ground-breaking trial underway to protect pregnant women from malaria
28 Jan 2011
WHO report calls for urgent action to protect malaria therapies
12 Jan 2011
Global plan for artemisinin resistance containment (GPARC)
11 Jan 2011
MMV's new CEO comes on board
05 Jan 2011
Letter from the CEO
22 Dec 2010
World Malaria Report shows scale-up of control activities is paying-off
14 Dec 2010
International status granted to three not-for-profit organizations in Switzerland
09 Dec 2010
WHO report calls for greater vigilance to allow early detection of artemisinin resistance
18 Nov 2010
Conclusive win of artesunate over quinine
08 Nov 2010
MMV-supported artesunate for injection receives WHO prequalification
08 Nov 2010
MMV announces new Chairman of the Board effective 2011
21 Oct 2010
Germany to give €20M to neglected disease research
20 Oct 2010
MMV appoints new CEO
12 Oct 2010
MMV ESAC member in Times Top 100 Scientists
11 Oct 2010
Optimizing development of combination therapies: the regulatory perspective
08 Oct 2010
Selecting the right partner drug: experts debate the issues
13 Sep 2010
MMV, Novartis and partners discover novel antimalarial drug candidate
03 Sep 2010
MMV becomes first PDP to make its IP freely available for neglected diseases research
16 Aug 2010
MMV to screen Ferrer compound library
15 Jul 2010
Malawi – determined to control malaria
14 Jul 2010
AstraZeneca and MMV join efforts in the fight against malaria
28 Jun 2010
Data from MMV-supported research now in the public domain
20 May 2010
Experts sought for Global Fund Technical Review Panel
14 May 2010
Over 5 million compounds screened
03 May 2010
MMV and Anacor join hands in hunt for new antimalarial compounds
26 Apr 2010
Ambrose Talisuna: Advocating for access
23 Apr 2010
MMV supports trials of a new preventive treatment option for pregnant women
23 Apr 2010
The Countdown to Counting Out Malaria in 2010
20 Apr 2010
Roll Back Malaria (RBM) Partnership Call for Nomination for Research and Academia constituency
08 Apr 2010
Pyramax® submitted to EMA for regulatory approval
08 Apr 2010
MMV welcomes Dennis Schmatz as CEO
07 Apr 2010
MMV co-hosted meeting for donors in Barcelona - an unqualified success
24 Mar 2010
MMV’s Project of the Year for 2009 goes to Spiroindolones
15 Mar 2010
Memorial donation in memory of Prof. Dr. Michaela von Freyhold
02 Feb 2010
MMV in Trends in Parasitology
01 Feb 2010
MMV-GSK compound library screening to be made public
20 Jan 2010
Join the CRIMALDDI online discussion
20 Jan 2010
World Malaria Report 2009
15 Dec 2009
MMV 10th Anniversary Seminars: presentations and video clips
04 Dec 2009
Outstanding review of MMV by Philanthropy Advisory Service
01 Dec 2009
MMV’s President and CEO to step down in 2010
23 Nov 2009
MMV and sanofi-aventis launch ambitious antimalarial monitoring programme
19 Nov 2009
MMV at ASTMH 2009
11 Nov 2009
MMV in Nature Reviews Drug Discovery
06 Nov 2009
MMV at MIM 2009
26 Oct 2009
MMV at a Glance - a brochure about MMV
22 Oct 2009
MMV receives $115 million from Gates Foundation
19 Oct 2009
MMV supports the need for subsidized antimalarials
12 Oct 2009
New EU-funded project to coordinate antimalarial drug research
24 Aug 2009
Price of Coartem® reduced for the third time in 8 years
13 Aug 2009
MMV and Treague take development of (+) Mefloquine into Phase I
10 Jul 2009
Dihydroartemisinin-piperaquine submitted to EMEA for regulatory approval
06 Jul 2009
Malaria and the G8
03 Jul 2009
MMV Annual Report 2008 published
01 Jun 2009
UNITAID supports new fund aimed at artemisinin extractors
19 May 2009
MMV to use HEOS database developed by SCYNEXIS
13 May 2009
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
next ›
last »